U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT07492160) titled 'Efficacy of Cabergoline in Inhibiting Lactation and Alleviating Breast Symptoms' on March 19.
Brief Summary: The goal of this clinical trial is to learn whether cabergoline can prevent lactation and reduce breast symptoms in pregnant people aged 18 years or older undergoing abortion or pregnancy loss between 12 and 18 weeks of gestation. The main questions it aims to answer are:
Does cabergoline decrease the proportion of participants who experience breast symptoms (including breast engorgement, milk leakage, tenderness, and need for pain relief) after abortion or pregnancy loss?
Does cabergoline reduce the severity of breast sym...